» Articles » PMID: 26296096

Behavior and Properties of Mature Lytic Granules at the Immunological Synapse of Human Cytotoxic T Lymphocytes

Overview
Journal PLoS One
Date 2015 Aug 22
PMID 26296096
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Killing of virally infected cells or tumor cells by cytotoxic T lymphocytes requires targeting of lytic granules to the junction between the CTL and its target. We used whole-cell patch clamp to measure the cell capacitance at fixed intracellular [Ca2+] to study fusion of lytic granules in human CTLs. Expression of a fluorescently labeled human granzyme B construct allowed identification of lytic granule fusion using total internal reflection fluorescence microscopy. In this way capacitance steps due to lytic granule fusion were identified. Our goal was to determine the size of fusing lytic granules and to describe their behavior at the plasma membrane. On average, 5.02 ± 3.09 (mean ± s.d.) lytic granules were released per CTL. The amplitude of lytic granule fusion events was ~ 3.3 fF consistent with a diameter of about 325 nm. Fusion latency was biphasic with time constants of 15.9 and 106 seconds. The dwell time of fusing lytic granules was exponentially distributed with a mean dwell time of 28.5 seconds. Fusion ended in spite of the continued presence of granules at the immune synapse. The mobility of fusing granules at the membrane was indistinguishable from that of lytic granules which failed to fuse. While dwelling at the plasma membrane lytic granules exhibit mobility consistent with docking interspersed with short periods of greater mobility. The failure of lytic granules to fuse when visible in TIRF at the membrane may indicate that a membrane-confined reaction is rate limiting.

Citing Articles

Lytic granule exocytosis at immune synapses: lessons from neuronal synapses.

Chang H, Schirra C, Pattu V, Krause E, Becherer U Front Immunol. 2023; 14:1177670.

PMID: 37275872 PMC: 10233144. DOI: 10.3389/fimmu.2023.1177670.


Faster cytotoxicity with age: Increased perforin and granzyme levels in cytotoxic CD8 T cells boost cancer cell elimination.

Zophel D, Angenendt A, Kaschek L, Ravichandran K, Hof C, Janku S Aging Cell. 2022; 21(8):e13668.

PMID: 35818124 PMC: 9381916. DOI: 10.1111/acel.13668.


Shedding Structured Light on Molecular Immunity: The Past, Present and Future of Immune Cell Super Resolution Microscopy.

Johanson T, Keenan C, Allan R Front Immunol. 2022; 12:754200.

PMID: 34975842 PMC: 8715013. DOI: 10.3389/fimmu.2021.754200.


Studying the biology of cytotoxic T lymphocytes in vivo with a fluorescent granzyme B-mTFP knock-in mouse.

Chitirala P, Chang H, Martzloff P, Harenberg C, Ravichandran K, Abdulreda M Elife. 2020; 9.

PMID: 32696761 PMC: 7375811. DOI: 10.7554/eLife.58065.


Cytotoxic Granule Exocytosis From Human Cytotoxic T Lymphocytes Is Mediated by VAMP7.

Chitirala P, Ravichandran K, Galgano D, Sleiman M, Krause E, Bryceson Y Front Immunol. 2019; 10:1855.

PMID: 31447853 PMC: 6692471. DOI: 10.3389/fimmu.2019.01855.


References
1.
Dudenhoffer-Pfeifer M, Schirra C, Pattu V, Halimani M, Maier-Peuschel M, Marshall M . Different Munc13 isoforms function as priming factors in lytic granule release from murine cytotoxic T lymphocytes. Traffic. 2013; 14(7):798-809. DOI: 10.1111/tra.12074. View

2.
Zhang N, Bevan M . CD8(+) T cells: foot soldiers of the immune system. Immunity. 2011; 35(2):161-8. PMC: 3303224. DOI: 10.1016/j.immuni.2011.07.010. View

3.
Jahn R, Scheller R . SNAREs--engines for membrane fusion. Nat Rev Mol Cell Biol. 2006; 7(9):631-43. DOI: 10.1038/nrm2002. View

4.
Soares H, Henriques R, Sachse M, Ventimiglia L, Alonso M, Zimmer C . Regulated vesicle fusion generates signaling nanoterritories that control T cell activation at the immunological synapse. J Exp Med. 2013; 210(11):2415-33. PMC: 3804939. DOI: 10.1084/jem.20130150. View

5.
Grossman W, Verbsky J, Tollefsen B, Kemper C, Atkinson J, Ley T . Differential expression of granzymes A and B in human cytotoxic lymphocyte subsets and T regulatory cells. Blood. 2004; 104(9):2840-8. DOI: 10.1182/blood-2004-03-0859. View